Statutory Committee inquiries
The Statutory Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, at 9.30am on Tuesday 20, Wednesday 21 and Thursday 22 February 2007 to hear the following matters:
1. The committee will hear the new inquiry into a complaint by the Council
of the Society against Rosalie Mary Pattison (registration number 66575),
which alleges that taking for the purposes of self-medication and/or
for unknown purposes, dishonestly and without the authority of a prescription,
dihydrocodeine tablets, loperamide tablets, diazepam 5mg and 10mg tablets,
omeprazole tablets, and Sudafed Plus tablets belonging to her employer,
may amount to misconduct.
2. The committee will resume the inquiry into a complaint by the Council of
the Society against Neil Hutchinson (registration number 79982) and Carol
Janette Hutchinson (registration number 79981) which alleges, in relation to Mr Hutchinson,
that a number of dispensing errors; the supply of a Controlled Drug, namely
30 Concerta X tablets, against a prescription for 14 such tablets; a failure
to comply with the labelling regulations; a breach of Regulation 19 of the
Misuse of Drugs Regulations 2001 relating to record-keeping; a failure to supply
a patient with his medication and the pharmacy’s failure to deal with
the subsequent complaint appropriately; the supply of medication to a patient
without reference to a prescription or a copy prescription and without checking
with the prescriber; an over-supply of candesartan tablets and a failure to
label this supply accurately; a failure to keep a verifiable audit trail of
the supply of prescription only medication; the supply of medication to a patient
by reference only to previously incorrectly supplied medication and the labelling
from an old monitored dosage system pack; a failure to act in the best interests
of a patient; a failure to deal with a patient’s mother in a professional
and courteous manner; a failure as superintendent pharmacist to have in place
a system to identify each pharmacist responsible for particular supply; a failure
to heed the advice of the Society; a failure to have in place adequate procedures
for dispensing in monitored dosage systems; the pharmacy’s inadequate
procedures for dealing with errors and complaints; an unacceptably dirty and
untidy pharmacy; a failure to assess or remove date-expired chemicals and/or
medication; the presence at the pharmacy of patient returned medication, including
prescription-only medication, on a stairway to which customers had access,
in the stockroom and in the office; and the dispensing of owings without reference
to the relevant prescription, may amount to misconduct. In relation to Mrs
Hutchinson, the Society’s Council alleges that the supply of a Controlled
Drug, namely 30 Concerta X tablets, against a prescription for 14 such tablets;
a breach of Regulation 19 of the Misuse of Drugs Regulations 2001 relating
to record-keeping; the pharmacy’s failure to deal appropriately with
a complaint; a failure of the pharmacy to keep a verifiable audit trail of
the supply of prescription-only medication; the failure of the pharmacy to
have in place a system to identify each pharmacist responsible for a particular
supply; a failure to heed the advice of the Society; the supply of medication
to a patient using only previously incorrect medication and labelling from
an old monitored dosage system pack; the pharmacy’s failure to have in
place adequate procedures governing dispensing in monitored dosage systems;
the pharmacy’s inadequate procedures for dealing with errors and complaints;
an unacceptably dirty and untidy pharmacy; a failure to assess or remove date-expired
chemicals and/or medicines; the presence at the pharmacy of patient-returned
medication, including prescription only medication, on a stairway to which
customers had access, in the stockroom and in the office; and a failure to
record maximum and minimum refrigerator temperatures daily, may amount to misconduct.
3. The committee will deliver its determination relating to the application
for restoration to the Register from Hasmukhkant Nanji Badiani.
4. The committee will deliver its determination of the inquiry into a complaint
by the Council of the Society against Anilkumar Ishverbhai Patel (registration
number 70633) and Hemantika Anil Patel (registration number 71179).
David Gomez
Secretary to the Statutory Committee |
The
Pharmaceutical Journal